HDAC Inhibitor Market Trends in Drug Discovery, Clinical Research, and Development to 2034
HDAC Inhibitor Market is supported by increasing pharmaceutical research expenditure. Investment in innovative cancer therapies is encouraging the discovery and evaluation of epigenetic medicines for diseases with limited treatment options. The HDAC Inhibitor Market was valued at US$ 1.42 billion in 2025 and is projected to reach US$ 2.65 billion by 2034, registering a CAGR of 7.18% during...
0 Yorumlar 0 hisse senetleri 173 Views 0 önizleme